Clorox (NYSE:CLX) Price Target Raised to $111.00

Clorox (NYSE:CLX) had its price objective increased by TD Cowen from $108.00 to $111.00 in a research report released on Wednesday,MarketScreener reports. They currently have a hold rating on the stock.

Several other equities analysts have also recently weighed in on CLX. Wall Street Zen cut Clorox from a “hold” rating to a “sell” rating in a research report on Saturday, January 24th. Royal Bank Of Canada set a $132.00 target price on Clorox in a report on Wednesday. Barclays reissued an “underweight” rating and issued a $109.00 price target on shares of Clorox in a report on Friday, January 16th. Rothschild & Co Redburn reduced their price objective on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. Finally, The Goldman Sachs Group lowered their target price on shares of Clorox from $110.00 to $94.00 and set a “sell” rating on the stock in a research note on Wednesday, January 7th. One analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and five have given a Sell rating to the company. According to MarketBeat, Clorox has a consensus rating of “Reduce” and an average target price of $117.93.

Clorox Price Performance

Shares of NYSE:CLX opened at $119.52 on Wednesday. The company has a 50-day moving average price of $105.83 and a two-hundred day moving average price of $113.97. Clorox has a twelve month low of $96.66 and a twelve month high of $159.04. The company has a quick ratio of 0.50, a current ratio of 0.74 and a debt-to-equity ratio of 71.03. The firm has a market capitalization of $14.45 billion, a PE ratio of 19.53, a P/E/G ratio of 0.57 and a beta of 0.59.

Clorox (NYSE:CLX) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period last year, the business posted $1.55 earnings per share. The firm’s quarterly revenue was down .8% on a year-over-year basis. Equities analysts forecast that Clorox will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be paid a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s dividend payout ratio is currently 81.05%.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber purchased 4,000 shares of the company’s stock in a transaction on Friday, November 21st. The stock was purchased at an average price of $104.13 per share, with a total value of $416,520.00. Following the completion of the purchase, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. This trade represents a 44.44% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.63% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Clorox by 4.0% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after purchasing an additional 514 shares during the last quarter. Woodline Partners LP lifted its stake in shares of Clorox by 253.7% in the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after acquiring an additional 7,465 shares during the last quarter. Ameritas Advisory Services LLC bought a new stake in shares of Clorox in the 2nd quarter valued at about $48,000. Belpointe Asset Management LLC boosted its holdings in Clorox by 10.5% during the 2nd quarter. Belpointe Asset Management LLC now owns 3,516 shares of the company’s stock valued at $422,000 after acquiring an additional 335 shares during the period. Finally, Shell Asset Management Co. grew its position in Clorox by 94.8% during the 2nd quarter. Shell Asset Management Co. now owns 16,079 shares of the company’s stock worth $1,931,000 after acquiring an additional 7,824 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox News Roundup

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Morgan Stanley raised its price target on CLX to $136 (maintained equal-weight), citing valuation/earnings dynamics — a catalyst supporting the stock’s rally. Clorox (NYSE:CLX) Price Target Raised to $136.00 at Morgan Stanley
• Positive Sentiment: Investor write-ups are bullish: a Seeking Alpha piece frames CLX as a defensive, dividend-rich value after “solid” Q2 results and attractive valuation — supporting buy interest from income-focused investors. Clorox: Solid Q2 Results And Cheap Valuation MakesThis Defensive Dividend Stock A Strong Buy
• Neutral Sentiment: TD Cowen nudged its price target to $111 and kept a Hold rating — a modest recalibration that tempers upside expectations despite the recent positive headlines. TD Cowen Adjusts Clorox Price Target
• Neutral Sentiment: Company reported mixed Q2 results and reaffirmed its 2026 outlook — revenue roughly flat year-over-year and an EPS miss by a few cents; reassurances on the outlook limit downside but leave questions on near-term margin recovery. Clorox Posts Mixed Q2 Results, Reaffirms 2026 Outlook
• Neutral Sentiment: Management is weighing a potential GOJO acquisition and finishing an ERP implementation; strategic moves could boost long-term growth but add execution risk in the near term. Clorox Weighs GOJO Deal And ERP Finish Against Softer Earnings
• Neutral Sentiment: Q2 earnings call transcript is available for deeper read on management commentary around pricing, cost savings and margin plans — useful for gauging execution risk. Clorox (CLX) Q2 2026 Earnings Call Transcript
• Negative Sentiment: Some brokerages have a consensus “Reduce” rating on CLX, which may cap upside as institutional flows react to conservative guidance and margin concerns. The Clorox Company Given Consensus Rating of “Reduce” by Brokerages
• Negative Sentiment: BofA flagged margin uncertainty after the Q2 EPS miss — a reminder that cost and margin recovery, not just revenue, will drive forecast revisions and investor sentiment. BofA Flags Margin Uncertainty for Clorox After Q2 Earnings Miss
• Neutral Sentiment: A Zacks piece highlights using its Earnings ESP tool to find staples stocks that might beat — general market research, not CLX-specific guidance, but could affect short-term trading interest. Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.